Clinical Roundup Inherited WNT9B mutation linked to increased prostate cancer risk, study finds February 07, 2025Vol.51 No.05
Clinical Roundup Healthy stem cells could turn into oral cancer, study finds February 07, 2025Vol.51 No.05
Clinical Roundup Urine test for prostate cancer could be used at home, study finds February 07, 2025Vol.51 No.05
Clinical Roundup Wistar researchers identify target to overcome treatment-resistant melanoma February 07, 2025Vol.51 No.05
Clinical Roundup Dual-targeted therapies + chemo shows high response rates in BRAF-mutated metastatic CRC, phase III trial shows January 31, 2025Vol.51 No.04
Clinical Roundup Opdivo + Yervoy show improvement in PFS for MSI-high, MMR- CRC in phase III trial January 31, 2025Vol.51 No.04
Clinical Roundup Genentech’s Itovebi demonstrated OS benefit in advanced breast cancer, phase III trial finds January 31, 2025Vol.51 No.04
Clinical Roundup In HER2+ CRC, anti-HER2 therapy may be less toxic alternative to EGFR inhibitors, phase II study finds January 31, 2025Vol.51 No.04
Clinical Roundup Chemo + immunotherapy achieve higher complete remission rates in DLBCL than either treatment alone, Mount Sinai trial finds January 31, 2025Vol.51 No.04
Clinical Roundup Adjuvant Celebrex may reduce risk of colon cancer recurrence in patients with evidence of ctDNA January 31, 2025Vol.51 No.04
